-
Cancer Drug Nilotinib Shows Promise for Parkinson's Patients
drugs
December 17, 2019
A drug used to fight chronic myeloid leukemia might also relieve symptoms of Parkinson's disease, a new study finds.
-
Many Long-Term Breast Cancer Survivors Die From Other Causes
drugs
December 17, 2019
Non-breast cancer (non-BC) causes of death represent a considerable proportion of deaths among patients diagnosed with BC, according to a study published online in Cancer.
-
Many Lung Cancer Patients Receive Meds That Prolong QTc Interval
drugs
December 17, 2019
A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval ...
-
Free tool simplifies cancer research
worldpharmanews
December 17, 2019
Every cell contains a vast number of proteins, each of which has a specific function, for example as a receptor for another molecule or an enzyme that catalyses chemical reactions.
-
Biomedical engineers develop system that allows for real-time observations of individual cells in colon
Expresspharma
December 16, 2019
Researchers expect the procedure to allow new investigations into the digestive system’s microbiome as well as the causes of diseases like...
-
For Some, Follicular Lymphoma May Be Curable
drugs
December 12, 2019
Some patients in remission from the blood cancer called follicular lymphoma can be considered cured, a new small study suggests.
-
Sanofi to acquire Synthorx for $2.5 B
biospectrumasia
December 12, 2019
Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders.
-
Insurance Disparities ID'd in Diagnosis of Late-Stage Melanoma
drugs
December 12, 2019
For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with ...
-
Microcapsules provide targeted chemotherapy drug delivery to cancer cells
europeanpharmaceuticalreview
December 12, 2019
Development of infrared light-sensitive microcapsules could be the future in targeted drug delivery for cancer treatment, says new research.
-
Merck to Acquire ArQule for $2.7B
ContractPharma
December 11, 2019
Diversifies oncology pipeline with expansion into targeted therapies that treat hematological malignancies.